Traws Pharma Inc. (NASDAQ: TRAW) on Wednesday shared interim data from an ongoing randomized, open-label Phase 2 with ratutrelvir, an investigational oral, ritonavir-free Mpro/3CL protease inhibitor.

Apple's latest phone has a lot in common with the previous model, but there are notable improvements to the camera, display and battery. Is it worth the upgrade? Abrar's interests include phones, ...

Instead, just use it without an account. Even though I have an existing account, I’ll sometimes use ChatGPT without signing in if I need to ask a basic question but don’t want the conversation to be ...

This new update is not all good news. Samsung has released its long-awaited One UI 8.5 beta for the Galaxy S25, “introducing new and easier ways to create, connect and stay safe.” And while the latest ...

American Eagle expects fourth-quarter sales to grow at an even higher rate after its controversial Sydney Sweeney jeans ad captured national attention. The clothing company raised its outlook for ...

TD Ameritrade, Inc. has been acquired by Charles Schwab, and all accounts have been moved. You have $1,000 saved and you're trying to figure out what to do with it. It would be a significant amount of ...

The tech giant has been an investor in SpaceX since 2015, when it was worth a fraction of its potential value SpaceX dominates the rocket-launch industry, and is set to send some 90% of the world's ...